GREENFIELD, Ind. / Feb 23, 2023 / Business Wire / Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Bank of America 2023 Animal Health Summit on Thursday, March 2, 2023. Jeff Simmons, president and CEO, and Todd Young, executive vice president and CFO, will represent the company and respond to questions from analysts at 4:40 p.m. ET.
A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose™ Sustainability Pledges –all to advance the health of animals, people, and the planet. Learn more at elanco.com.
| Last Trade: | US$12.06 |
| Daily Change: | -0.04 -0.33 |
| Daily Volume: | 3,196,796 |
| Market Cap: | US$5.960B |
November 15, 2024 November 07, 2024 September 19, 2024 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
